Debrisoft Every T.I.M.E.
What is T.I.M.E.?
The T.I.M.E concept for wound bed preparation, introduced in 2002, is still one of the most popular concepts guiding clinicians to identify and breakdown local barriers to wound healing.
The 4 steps of successful wound bed preparation according to T.I.M.E. are:
- Tissue Management
- Inflammation or Infection Control
- Moisture balance
- Edge epithelial advancement
These steps need to be addressed systematically so wound healing can take place.
Enabling a clean wound bed, by gently removing devitalized cell debris, reducing potentially harmful bacteria and biofilm in the wound bed and periwound skin and the time-saving cleansing of edges and periwound skin are only a couple of Debrisoft's benefits.
Debrisoft. Every T.I.M.E.
Tissue management
Callus, foreign bodies, exudate, biofilm, debris or slough can cause wounds to stall and not progress further to the next wound healing phase. Choosing the appropriate method to remove it is the key to successful wound bed preparation.
Wound cleansing and debridement
Tackle two steps at once with Debrisoft
Debrisoft provides effective wound bed preparation because it combines wound cleansing and mechanical debridement in one step. Once hydrated with a wound cleansing solution, Debrisoft's award-winning technology — the monofilament fibers — go into the wound bed or periwound skin and loosens debris and non-viable tissue gently through circular motion. Due to the high density of monofilament fiber composite, debris and non-viable tissue are lifted, bound and safely removed, while providing a virtually painless experience for the patient.
Discover its unique benefits.
Debrisoft. Every T.I.M.E.
Inflammation or infection control
A natural part of the wound healing process that must be managed appropriately.
Inflammation is a natural part of the wound healing process and a physiological response to wounding which is required for wound healing to progress (Leaper et al, 2012). Chronic wounds fail to progress from the inflammation phase due to imbalance of inflammatory cells, cytokines, growth factors and/or proteases, such as matrix metalloproteinases (MMPs).
An additional challenge to wound infection is the presence of biofilm. Biofilm is a structured community of microbial cells, enclosed in a polymeric matrix, and adherent to natural or artificial surfaces or to themselves. Those communities are surrounded by their own secreted matrix of extracellular polymeric substance (EPS) that provides structural integrity and protects them from external threats. Biofilms are characterized by significant tolerance to antimicrobial agents, disinfectants, and the host’s immune defenses (Snyder et al, 2017).
Disrupt biofilm.
Disrupt biofilm before applying antimicrobial dressings to prevent regrowth.
60–90% of all chronic wounds have biofilms but it is not always detected with the naked eye. Harries, Bosanquet and Harding (2016), suggest certain clinical indicators raising suspicion to the presence of biofilm: antibiotic failure, Infection > 30 days duration, friable granulation tissue and a gelatinous material removable from wound surface that quickly rebuilds.
One fact that experts agree on is that biofilms are characterized by significant tolerance to antimicrobial agents and that debridement and disruption of biofilm is necessary as a first step before applying antimicrobials for potential suppressing of reformation.
2 pads. 15 minutes.
See Debrisoft's fast effect on disrupting and removing bacteria/biofilm.
Case Study
- Patient LC. A 26 year old male patient with a post trauma DVT.
- History of leg ulceration for the last 8 years.
- Images were taken before and after the treatment with Debrisoft. The leg was photographed with a wound intelligence device leveraging the principles of fluorescence to identify potentially harmful bacteria.
Figure 1 (4/12/2018) Before treatment with Debrisoft showing red/orange areas typically associated with the presence of potentially harmful levels of bacteria.
Figure 2 (4/12/2018) After first treatment with Debrisoft, uncovering deep pockets of potentially harmful levels of bacteria (red pockets).
Figure 3 (4/12/2018) After second treatment with Debrisoft, showing removal of deeper pockets of bacteria.
Source: Morris, C. “Evaluating the removal of bacteria and biofilm with monofilament fibre debridement technology, compared to a cleaning product using a wound intelligence device”, EWMA 2019, Krakow, PL
Suprasorb, Flivasorb, and ReadyWrap in T.I.M.E.
Moisture balance
For a moist wound healing environment.
Suprasorb® G
Smart dressing with cooling pain relief built-in.
Suprasorb G addresses the challenges of a dry to moderately exuding wound. Different to other hydrogel based wound dressings, it maintains the moisture balance in the wound bed. It proved effective in a wide range of different wounds as skin tears, moderate burns including radiation therapy burns, chronic wounds, especially with venous leg ulcers under compression, malignant wounds and extravasation injuries.
Suprasorb G smart dressing shows impressive results, absorbing exudate or donating moisture where necessary, minimizing the risk of moisture associated skin damage (MASD).
Case Study
- Complicated skin tear treated with Suprasorb G before and after one week
Complicated skin tear treated with Suprasorb G, before and after one week Brackin, T., (2018) “Effectiveness of Necrotic Tissue Removal with Dynamic Gel Dressing and Monofilament Debridement”, 2018 SAWC Spring, Charlotte, USA
Flivasorb®/Vliwasorb®
High performance — even under pressure.
When seeing patients with higher exuding wounds, Flivasorb and Flivasorb Border are the right dressings to effectively address this situation. Its high absorption and retention capacity makes it the ideal dressing in combination with compression therapy, protecting the bandages and absorbing exudate without having to change the dressing daily. The dressing wear time is extended up to 7 days, saving costs and making it a cost effective alternative to other dressings. The flexible Flivasorb Border dressing additionally supports to easily address difficult to dress areas.
The absorption capacity of Flivasorb® is more than twice as that of traditional absorbent dressings with fiber core.
Case Study
- 75 y/o male with pressure ulcer, high exudate level
- Previous treatment: Border foam dressings, daily dressing change needed, high pain and beginning maceration
- Flivasorb Border: dressing change alternating days or every three days, primary antimicrobial wound dressing became more effective as it stayed in place, level of pain decreased, wound size reduction, beginning of wound healing
3 August
3 August
8 August
15 August
28 August
Source: Deborah Kattell and Lynne Whitmore. Tissue Viability Specialist Nurses
ReadyWrap™
ReadyWrap is an adjustable variable compression wrap that provides patients and their caregivers an easy-to-use solution to support wound healing and edema management. This wrap provides clinically-effective compression therapy while supporting patient compliance with its unique alternating strapping system.
With ReadyWrap, you can be certain your patients will have an effective and comfortable garment that easily adjusts to their limb and donning abilities.
Debrisoft. Every T.I.M.E.
Edge epithelial advancement
See Debrisoft's fast effect on disrupting and removing bacteria/biofilm.
Case Study
- Patient with history of leg ulceration and chronic renal failure before treatment with Debrisoft
- Red/orange areas typically associated with the presence of potentially harmful levels of bacteria
Figure 1 Before treatment with Debrisoft showing red/orange areas typically associated with the presence of potentially harmful levels of bacteria.
Figure 2 No sign of potentially harmful bacteria after treatment with 2 Debrisoft Pads (4x4).
Source: Morris, C. “Evaluating the removal of bacteria and biofilm with monofilament fibre debridement technology, compared to a cleaning product using a wound intelligence device”, EWMA 2019, Krakow, PL